Part 01 · The Question→Part 02 · The Record→Part 03 · The File
← Part 02
Inspection Case File · CF06 · Part 03 of 03

The complete authorization record. Ready to produce during inspection.

The completed reference DDR plus everything you need to build defensible records before your next inspection. Or the full inspection set if this isn't isolated to one decision class in your facility.

Built around 21 CFR 211.192 · ICH Q10 · Used by Quality and Validation leaders preparing for FDA and EMA inspections
Where this leaves you

You've seen the inspector's question, the gap in the file, the five required fields, and the reference DDR excerpt. The structure is no longer a mystery. The decision now is what to put in your facility's records.

The Complete File

Two ways to close the gap.

Get the complete case file for this scenario, or the full inspection set covering all ten decision classes most facilities miss.

For This Decision Class Most Common
CF06 · The Complete Case File
The completed reference DDR plus everything you need to build defensible records before your next inspection.

What's Included

  • The seven-section blank Decision Defense Record template, with field-level guidance and print-to-PDF formatting for controlled record use
  • The complete reference DDR for Atorvastatin Tablets 40 mg — CAPA-2023-0894 — fully authorized, ready as a model
  • Full confounding-factors evaluation (the field most files don't have)
  • The evidence checklist — 10 items to gather before authorizing any CAPA effectiveness conclusion
  • The exact 483 observation language an investigator drafts when this gap appears
  • Cited regulatory framework: 21 CFR 211.192 · ICH Q10 · 21 CFR 820.100
If your QA Director, external auditor, or Qualified Person reviews this and concludes it does not match inspection expectations, request a refund. No questions, no friction.
$149 One-time · Delivered immediately
Unlock the Completed Record — $149
If This Isn't Isolated Save $615
The Compliance Executive Inspection Defense Series
If your facility has gaps in more than one decision class — batch release, OOS, change control, CAPA, data integrity, and six others — the bundle covers the full inspection surface.

Everything in CF06, plus:

  • CF01 Process Validation Conclusion — when validation reports are signed but the conclusion logic isn't recorded
  • CF02 Batch Release Authorization — when release under an open deviation cannot be reconstructed from the record
  • CF03 OOS Investigation Closure — when laboratory error is concluded without documented elimination of assignable cause
  • CF04 Deviation Risk Assessment — when no-impact is concluded without documented risk evaluation
  • CF05 Change Control Risk Categorization — when 'minor' or 'like-for-like' lacks documented basis
  • CF07 Data Integrity Determination — when audit trail anomalies are explained but not documented
  • CF08 Supplier Qualification — when approval rationale cannot be reconstructed
  • CF09 Stability OOT Disposition — when no-impact lacks defensible basis
  • CF10 Complaint Investigation — when no-action determination cannot be defended
$875 All 10 · vs. $1,490 individually
Get the Full Inspection Set →
Why now

FDA inspections occur on a 2-year cycle. Authorization records take longer than that to build well. Building under inspection pressure is not the same as having one in the file when the investigator arrives.

The 483
"Failure to document the scientific and risk-based rationale used to justify the conclusion that the corrective action and preventive action were effective, including the specific evidence supporting the determination that recurrence had been prevented and the basis on which the observation period was deemed sufficient. The CAPA closure record establishes that the action was completed but does not reconstruct the reasoning that justified the effectiveness conclusion."
21 CFR 211.192. The observation that this case file is built to prevent.
Common Questions

What buyers ask before they purchase.

Is this a template I can use immediately?
Yes. The $149 case file includes the blank DDR you can complete with your facility's data and produce as a controlled record, plus the completed reference example, evidence checklist, and 483 reference language.
What format is the file?
Web page formatted for print-to-PDF. Document control header, numbered sections, monospace citations — designed to look like a controlled record. Print directly from the browser, save as PDF, attach to your QMS.
Does this replace my QMS deviation workflow?
No. ComplianceWorxs sits above your existing QMS. Your QMS captures the deviation, the investigation, and the CAPA closure. The Decision Defense Record captures the authorization logic behind the effectiveness conclusion — the part most QMS workflows do not capture, which is the gap an investigator cites.
Is this scenario-specific or general?
CF06 is specific to CAPA effectiveness closure under 21 CFR 211.192. The reference example is packaging operations specific. The five-field structure applies to any CAPA effectiveness closure in an FDA-regulated facility.
What happens after I purchase?
You receive immediate access to the complete case file. No account required. Delivery is instant via email and direct browser access.
Refund policy?
If the $149 case file does not match inspection expectations on review by your QA Director, external auditor, or Qualified Person, request a refund. No questions, no friction. The bundle does not carry a refund — it is priced as a commitment offer for buyers who recognize the pattern across multiple decision classes.
If you're not ready yet

Get the blank record structure by email.

A starting reference, no card required. Most buyers who use the blank template return for the complete case file within 2-3 weeks.

Decision Time

The complete case file or the full inspection set. Pick the level that matches your exposure.

Case File · $149 Bundle · $875

Used by Quality and Validation leaders preparing for FDA and EMA inspections.
21 CFR 211.192 · ICH Q10 · 21 CFR 820.100